🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the safety and immunogenicity of new for...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-12-09
Trial ID
NCT01248884
Treatments Being Tested
The purpose of this study is to assess the immunogenicity and safety of the...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-09-19
Trial ID
NCT02853929
Treatments Being Tested
Assess immuno, reacto of the 10-valent pneumococcal vaccine after 2 doses (...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-01-01
Trial ID
NCT00307034
Treatments Being Tested
Young infants are most vulnerable to severe disease and even death when inf...
Status
Completed
Location
Chulalongkorn University
Start Date
2015-04
Trial ID
NCT02408926
Treatments Being Tested
This study will evaluate the immunogenicity of the co-administration of dif...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-09-30
Trial ID
NCT00352963
Treatments Being Tested
Primary Objective: To describe the persistence of Hep B antibodies (Ab) at...
Status
Completed
Location
Multiple Locations
Start Date
2015-11
Trial ID
NCT02610348
This study evaluates the immunogenicity and safety of Infanrix hexa™ (DTPa-...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04-16
Trial ID
NCT01353703
Treatments Being Tested
This is a booster study in 2 groups of healthy children less than 3 years o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-08-22
Trial ID
NCT00513409
Treatments Being Tested
Primary :1.To demonstrate a sufficient immune response of rMenB+OMV NZ, whe...
Status
Completed
Location
Novartis Investigational Site Nr. 59
Start Date
2008-08
Trial ID
NCT00721396
The purpose of this study is to assess the immunogenicity and safety of GSK...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-04-16
Trial ID
NCT02096263